Access cutting-edge liver cancer treatment through this clinical trial at a research site in Pasadena. Study-provided care at no cost to qualified participants.
Access liver cancer specialists in Pasadena at no cost
This study follows strict safety protocols and ethical guidelines
All study-related liver cancer treatment provided free
The purpose of this study is to assess the safety of atezolizumab and bevacizumab, or atezolizumab alone, as first-line treatment in participants with unresectable, locally advanced or metastatic hepatocellular carcinoma (HCC) with Child-Pugh B7 or B8 cirrhosis.
Sponsor: Genentech, Inc.
Check if you qualify for this liver cancer clinical trial in Pasadena, CA
If you're searching for liver cancer treatment options in Pasadena, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Pasadena research site is actively enrolling participants for this clinical trial. You'll receive care from experienced liver cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.